Evaluation of Cardiac Adverse Events Associated with Carfilzomib Using a Japanese Real-World Database
Conclusions: This study suggests that the early signs and symptoms of potential fatal heart failure should be monitored during carfilzomib treatment.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Cardiology | Congestive Heart Failure | Databases & Libraries | Heart | Heart Failure | Japan Health | Medical Devices | Myeloma | Study